Dr. Peng Kezheng specializes in providing legal services related to intellectual property, including patent prosecution, patent portfolio management, reexamination, invalidation, third-party opinions, freedom-to-operate (FTO) searches and analysis, intellectual property due diligence. With extensive experience, Dr. Peng has successfully assisted numerous clients in navigating patent issues in various jurisdictions such as China, the United States, Europe, Japan, and South Korea. Additionally, Dr. Peng has provided support for clients to assess intellectual property-related risks in various projects including investment, financing, IPO, transactions, and licensing.
Dr. Peng's expertise spans diverse technical fields including medical and pharmaceutical, life sciences, and chemical materials, with a particular strength in areas such as antibodies, macromolecule drugs, cell therapy, gene therapy, omics sequencing, industrial microorganisms, diagnostic methods, biomarkers, and artificial intelligence applications in the medical area. Dr. Peng has served a wide range of clients including large publicly traded companies, investment firms, emerging startup companies, universities, and research institutions.
Prior to his legal career, Dr. Peng published many research papers in leading international journals in the fields of life sciences, medicine, and pharmacy. Leveraging his scientific background, Dr. Peng can deeply understand his clients' technologies and devises optimal patent strategies to enhance the commercial value of their innovations. Before joining Han Kun Law Offices, Dr. Peng completed an internship with King & Wood Mallesons.
